
Waikato
Clinical Research (2008) Ltd is a well established clinical trials
unit which has continued with the facilities and management staff of
Waikato Clinical
Research which was founded in 1978 by Dr Colin
Brown. Waikato Clinical Research has performed a wide range of
studies from Phase II to post marketing studies including post operative
medical device studies and numerous pharmacokinetic
studies.
Waikato Clinical Research has an excellent and well known
international reputation for providing high quality data. The site
was instrumental in the development
program for Ketorolac (Toradol) and
studies undertaken by Waikato Clinical Research have had a significant effect on
the understanding and management of post
operative pain.
Over many
years Waikato Clinical Research has worked with
US, other international pharmaceutical companies and clinical research
organisations. We have access to independent monitors who have worked with
Waikato Clinical Research over a number of years.
As Waikato Clinical
Research is an independent entity our processes in place ensure for the sponsor
a quick start-up time, ethical approval within twenty days of submission
and fast recruitment with realistic time frames.